Summit Therapeutics Inc vs Atlassian Corporation PLC — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while Atlassian Corporation PLC trades at $90.58 (market cap $23.67B). The key difference: Atlassian Corporation PLC is far larger — about 2.3× Summit Therapeutics Inc's market cap, and Atlassian Corporation PLC is trading nearer its 52-week high, Summit Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| SMMT | TEAM | |
|---|---|---|
Market Cap | $10.48B | $23.67B |
Sector | Health | Technology |
52-Week High | $29.32 | $203.00 |
52-Week Low | $13.05 | $57.15 |
Enterprise Value | $9.90B | $23.78B |
Trailing returns across standard periods
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →Atlassian produces software that helps teams work together more efficiently and effectively. The company provides project planning and management software, collaboration tools, and IT help desk solutions. The company operates in four segments: subscriptions (term licenses and cloud agreements), maintenance (annual maintenance contracts that provide support and periodic updates and are generally attached to perpetual license sales), perpetual license (upfront sale for indefinite usage of the software), and other (training, strategic consulting, and revenue from the Atlassian Marketplace app store). Atlassian was founded in 2002 and is headquartered in Sydney.
Read more on TEAM →